Figure 1.

Allocation of treatment groups for female dogs treated for bacterial cystitis with SDS treatment versus long‐duration beta‐lactam treatment. Lines with arrows indicate progression of dogs that entered the study, clinically responded to treatment, and did not have a recurrence of clinical signs. Lines with terminal ends indicate when dogs were excluded or withdrawn from the study. SDS, short‐duration sulfonamide treatment; LDBL, long‐duration beta‐lactam treatment; n, number of dogs in group.